Protocol No.: 20200469
- Title
- A Phase 1b Study Evaluating the Safety and Efficacy of First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects with Extensive Stage Small Cell Lung Cancer
- Principal Investigator
- Almubarak, Mohammed
- Phase
- I
- Age Group
- Adult
- Applicable Disease Site
- Lung Cancer
- Participating Institution
- Mary Babb Randolph Cancer Center
- Contact
- Carla Ross, RN
- Senior Research Nurse
- Phone: +1 304-293-2633
- Email: carla.ross@hsc.wvu.edu